Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 Apr 16:13:15.
doi: 10.1186/1471-2415-13-15.

Persistent unsealed internal limiting membrane after Nd:YAG laser treatment for valsalva retinopathy

Affiliations
Case Reports

Persistent unsealed internal limiting membrane after Nd:YAG laser treatment for valsalva retinopathy

Ming Zou et al. BMC Ophthalmol. .

Abstract

Background: To report a long-term complication of unsealed and un-reattached internal limiting membrane in Valsalva retinopathy after neodymium-doped yttrium-aluminium-garnet (Nd:YAG) laser membranotomy.

Case presentation: A 41-year-old man presenting with a massive premacular hemorrhage due to Valsalva retinopathy underwent Nd:YAG laser membranotomy. During follow-up, best-corrected visual acuity, retinal alteration and optical coherence tomography (OCT) outcomes were documented. One month after membranotomy, his visual acuity improved to 20/20 and the hemorrhage resolved completely. At an 8-month follow-up visit, the fundus showed progressive wrinkling of the internal limiting membrane with the laser perforation located in the center. OCT showed a persistent unsealed and un-reattached internal limiting membrane.

Conclusions: Not all patients with Valslava retinopathy with premacular hemorrhage are appropriate candidates for laser membranotomy, especially patients with sub- internal limiting membrane hemorrhage. The key point for observation is the interface between internal limiting membrane and retinal surface. The long-term consequences of unsealed internal limiting membrane after Nd:YAG laser membranotomy require further understanding.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Fundus photograph (a) of the left eye in a 41-year-old man with Valsalva retinopathy showing a massive premacular hemorrhage. Corresponding SD-OCT reveals a dome-shaped hypo-reflective area consistent with blood (b). Above the level of settled blood there are two distinct membranes (c): the low reflective band of the posterior hyaloid surface (red arrow) and the hyper-reflective internal limiting membrane (ILM, white arrow). Fundus photography 1 month after laser (d) shows complete resolution of the hemorrhage. Corresponding SD-OCT shows the laser perforation in the ILM (e, blue arrow) and a sub-ILM hypo-reflective space (f). Fundus photography at 3 months (g) and 8 months (j) after the Nd:YAG laser membranotomy show progressive ILM wrinkling and striae radiating from the central perforation. Based on the OCT tracking system, the un-sealed ILM defect (blue arrow) is seen to persist at 3 months (h) and 8 months (k) after treatment; and the sub-ILM space also fails to show any substantial reduction in size at the 3-month (i) or 8-month (l) follow-up.

References

    1. Duane TD. Valsalva hemorrhagic retinopathy. Trans Am Ophthalmol Soc. 1972;70:298–313. - PMC - PubMed
    1. Gabel VP, Birngruber R, Gunther-Koszka H, Puliafito CA. Nd:YAG laser photodisruption of hemorrhagic detachment of the internal limiting membrane. Am J Ophthalmol. 1989;107:33–37. - PubMed
    1. Matonti F, Nadeau S, Denis D. Valsalva retinopathy treated by Nd:YAG laser. J Fr Ophtalmol. 2013;36:92. doi: 10.1016/j.jfo.2012.03.007. - DOI - PubMed
    1. Durukan AH, Kerimoglu H, Erdurman C, Demirel A, Karagul S. Long-term results of Nd:YAG laser treatment for premacular subhyaloid haemorrhage owing to valsalva retinopathy. Eye (Lond) 2008;22:214–218. doi: 10.1038/sj.eye.6702574. - DOI - PubMed
    1. Ulbig MW, Mangouritsas G, Rothbacher HH, Hamilton AM, McHugh JD. Long-term results after drainage of premacular subhyaloid hemorrhage into the vitreous with a pulsed Nd:YAG laser. Arch Ophthalmol. 1998;116:1465–1469. - PubMed

Publication types